Please check your internet connection and try again.
# Ecospirin 250/75mg Enteric-Coated Aspirin
## Overview
Ecospirin 250/75mg is a combination product containing enteric-coated aspirin. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. Its antiplatelet effect is also utilized in cardiovascular prophylaxis. The enteric coating is designed to delay absorption and reduce gastric irritation.
## Primary Indications
* Pain and inflammation associated with conditions like arthritis, musculoskeletal disorders.
* Cardiovascular risk reduction (secondary prevention of myocardial infarction and stroke) in patients with established cardiovascular disease or at high risk. *Note: Specific indication and dosing for cardiovascular prevention should be guided by established guidelines.*
## Adult Dosing
* **Pain and Inflammation:** Dosing varies significantly based on indication and severity. Typical doses range from 325 mg to 650 mg every 4-6 hours as needed. Maximum daily dose is generally 4000 mg.
* **Cardiovascular Prevention:** Typically 75 mg to 325 mg once daily. The specific dose is determined by cardiovascular risk assessment and patient profile.
## Pediatric Dosing
Aspirin is generally **not recommended** for children and adolescents under 18 years of age for pain or fever due to the risk of Reye's syndrome. Exceptions may exist for specific pediatric conditions under strict medical supervision.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Significant impairment may require dose reduction, though specific guidelines are lacking.
* **Hepatic Impairment:** Use with caution.
## Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulceration or gastrointestinal bleeding.
* History of aspirin-induced asthma or urticaria.
* Children and adolescents with viral infections (risk of Reye's syndrome).
* Severe renal or hepatic impairment.
* Late pregnancy (third trimester).
## Adverse Effects
* **Common:** Gastrointestinal upset, heartburn, nausea, dyspepsia.
* **Serious:** Gastrointestinal bleeding, ulceration, tinnitus (ringing in the ears), hearing loss, bronchospasm, anaphylaxis, hepatotoxicity, nephrotoxicity, Reye's syndrome (in children/adolescents).
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of gastrointestinal toxicity.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** Reduced efficacy of antihypertensives; increased risk of renal dysfunction.
* **Methotrexate:** Increased methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Reduced uricosuric effect.
* **Alcohol:** Increased risk of gastrointestinal bleeding.
## Monitoring
* Signs and symptoms of gastrointestinal bleeding (e.g., melena, hematemesis, abdominal pain).
* Renal function (especially in patients with pre-existing renal disease, dehydration, or concomitant use of nephrotoxic agents).
* Liver function tests (if indicated).
* Auditory symptoms (tinnitus).
## Clinical Pearls
* The enteric coating delays absorption and reduces gastric irritation but may also delay the onset of action.
* For urgent pain relief, immediate-release aspirin may be preferred.
* Low-dose aspirin (75-100 mg) is commonly used for long-term cardiovascular prophylaxis.
* Patients with asthma, nasal polyps, and aspirin sensitivity are at higher risk for severe reactions.
* Discontinue aspirin several days before elective surgery to reduce bleeding risk.
***
*Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult the most current prescribing information and a qualified healthcare professional for diagnosis, treatment, and management of medical conditions.*
